Takeshi Yuasa Shinichi Kitsukawa Gen Sukegawa Shinya Yamamoto Keita Kudo Kazunari Miyazawa Takuyo Kozuka Sohei Harada Junji Yonese
10.1186/1471-2407-13-3
BMC Cancer
2013 Jan 2;13:3.
CC BY
https://pubmed.ncbi.nlm.nih.gov/23282195/
Antineoplastic Agents / adverse effects Carcinoma, Renal Cell / secondary Carcinoma, Renal Cell / therapy Indoles / adverse effects Kidney Neoplasms / pathology Protein Kinase Inhibitors / adverse effects Pyrroles / adverse effects Radiation Pneumonitis / chemically induced Spinal Neoplasms / secondary Spinal Neoplasms / therapy Thoracic Vertebrae / drug effects Thoracic Vertebrae / radiation effects
Antineoplastic Agents / adverse effects Carcinoma, Renal Cell / secondary Carcinoma, Renal Cell / therapy Indoles / adverse effects Kidney Neoplasms / pathology Protein Kinase Inhibitors / adverse effects Pyrroles / adverse effects Radiation Pneumonitis / chemically induced Spinal Neoplasms / secondary Spinal Neoplasms / therapy Thoracic Vertebrae / drug effects Thoracic Vertebrae / radiation effects Case Reports Research Support, Non-U.S. Gov't Aged Carcinoma, Renal Cell / drug therapy Carcinoma, Renal Cell / radiotherapy Glucocorticoids / administration & dosage Humans Male Molecular Targeted Therapy Prednisolone / administration & dosage Pulse Therapy, Drug Radiation Dosage Radiation Pneumonitis / diagnostic imaging Radiation Pneumonitis / drug therapy Spinal Neoplasms / drug therapy Spinal Neoplasms / radiotherapy Sunitinib Time Factors Tomography, X-Ray Computed Treatment Outcome Antineoplastic Agents Glucocorticoids Indoles Protein Kinase Inhibitors Pyrroles Prednisolone Sunitinib
PMC3582599
23282195
Early onset recall pneumonitis during targeted therapy with sunitinib
2013